Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 658-666

  Dluzen, Dean E ^a   McDermott, Janet L ^a,b   Liu, Binjun ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Edwin Shaw Hospital   (United States)

Author keywords

L DOPA; Neuroprotectant; Neurotoxin; Nigrostriatal system

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ESTROGEN;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DOPAMINE RELEASE; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; STRIATE CORTEX;

ANIMALIA;

EID: 0030026611     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020658.x     Document Type: Article

References (55)

1. Arbuthnott G. W., Fairbrother I. S., and Butcher S. P. (1990) Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. Pharmacol. Ther. 48, 281-293.
2. Ayala C. A. and Jaffe E. H. (1993) Pharmacological modulation of endogenous dopamine and DOPAC outflow from nucleus accumbens. Neuropharmacology 32, 1401-1409.
3. Bauer R. B., Stevens C., Reveno W. S., and Rosenbaum H. (1982) L-DOPA treatment of Parkinson's disease: a ten-year follow-up study. J. Am. Geriatr. Soc. 30, 322-325.
4. Becker J. B and Beer M. E. (1986) The influence of estrogen on nigrostriatal dopamine activity: behavior and neurochemical evidence for both pre- and postsynaptic components. Behav. Brain Res. 19, 27-33.
5. Becker J. B. and Cha J.-H. (1989) Estrous cycle-dependent variations in amphetamine-induced behaviors and strialal dopamine release assessed with microdialysis. Behav. Brain Res. 35, 117-125.
6. Becker J B., Snyder P. J., Miller M. M., Westgate S. A., and Jenuwine M. J. (1987) The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacol Biochem. Behav. 27, 53-59.
7. Bedard P. J., Langelier P., and Villeneuve A. (1977) Oestrogens and extrapyramidal system. Lancet 2, 1367-1368.
8. Bedard P. J., Di Paolo T., Langelier P., Poyet P., and Labrie F. (1981) Behavioral and biochemical evidence of an effect of estradiol on striatal dopamine receptors, in Steroid Hormone Regulation of the Brain (Fuxe K., Gustafsson J. A., and Welterberg L., eds), pp. 331-339. Pergamon Press, Oxford.
9. Bitar M. S., Ota M., Linnoila M., and Shapiro B. H. (1991) Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psyckoneuroendocrinology 16, 547-557.
10. Bronson F. H. and Maruniak J. A. (1975) Male-induced puberty in female mice: evidence for a synergistic action of social cues. Biol. Reprod. 13, 94-98.
11. Burchtnsky S. G. and Kuznetsova S M. (1992) Brain monoamine oxidase and aging: a review. Arch. Gerontol. Geriatr. 14, 1-15.
12. Crowley W. R., O'Donohue T. L., and Jacobowitz D. M. (1978) Changes in catecholamine content in discrete brain nuclei during the estrous cycle of the rat. Brain Res. 147, 315-326.
13. Date L, Felten D. L., and Felten S. Y. (1990) Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res. 519, 266-276.
14. Di Paolo T., Falardeau P., and Morissette M. (1988) Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life. Sci. 43, 665-672.
15. Diamond S. G., Markham C. H., Hoehn M. M., McDowell F. H., and Meunter M. D. (1990) An examination of male-female differences in the progression of Parkinson's disease. Neurology 40, 763-766.
16. Dluzen D. E. and Ramirez V. D. (1985) In vitro dopamine release from the rat striatum: diurnal rhythm and its modification by the estrous cycle. Neuroendocrinology 41, 97-100.
17. Dluzen D. E. and Ramirez V. D. (1990) In vivo changes in responsiveness of the caudate nucleus to L-DOPA infusion as a function of the estrous cycle. Brain Res. 536, 163-168.
18. Dorce V. A. C. and Palermo-Neto J. (1988) Effect of ovariectomy and of estrogen administration on some dopamine-related behaviors in the rat. Braz. J. Med. Res. 21, 313-320.
19. 3H-labeled monoamines by hypothalamic tissue in vitro. Brain Res. 73, 321-331.
20. Falardeau P. and Di Paolo T. (1987) Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences. Neurosci. Lett. 74, 43-48.
21. Fernandez-Ruiz J. J., Hernandez M. L., de Miguel R., and Ramos J A. (1991) Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats. J. Neural Transm. 85, 223-229.
22. Gerlach M., Riederer P., Przuntek H., and Youdim M. B. H. (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208, 273-286.
23. Giovanni A., Sieber B.-A., Heikkila R. E., and Sonsalla P. K. (1991) Correlation between the neostriatal content of the 1-methyl-4-phenylpyridimum species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J. Pharmacol. Exp. Ther. 257, 691-697
24. Glazer W. M., Naftolin F., Moore D. C., Bowers M. B., and MacLusky N. J. (1983) The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women. Psychoneuraendacrinology 8, 429-434.
25. Gomez-Mancilla B. and Bedard P. J. (1992) Effect of estrogen and progesterone on L-DOPA induced dyskinesia in MPTP-treated monkeys. Neurosci. Lett. 135, 129-132.
26. Gordon J. H. (1980) Modulation of apomorphme-induced stereotypy by estrogen: time course and dose response. Brain Res. Bull. 5, 679-682.
27. Gupta M., Gupta B. K., Thomas R., Bruemmer V., Sladek J. R. Jr., and Felten D. L. (1986) Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults. Neurosci. Lett. 70, 326-331.
28. Heikkila R. E., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224, 1451-1453.
29. Hruska R. E. (1986) Elevation of striatal dopamine receptors by estrogen: dose and time studies. J. Neurochem. 47, 1908-1915.
30. Javitch J. A., D'Amato R. J., Stritmatter S. M., and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
31. + transport. Synapse 13, 58-62.
32. Kurtzke J. F. and Goldberg I. D. (1988) Parkinsonism death rates by race, sex and geography. Neurology 38, 1558-1561.
33. Li S-c., Shoenberg B. S., Wang C-c., Cheng X-m., Rui D-y., Bolis C. L., and Schoenberg D. G. (1985) A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch. Neurol. 42, 655-657.
34. Lindey S. E., Gunnet J. W., Lookingland K. J., and Moore K. (1990) 3,4-Dihydroxyphenylacetic acid concentrations in the intermediate lobe and posterior pituitary gland as an index of tuberonypophysial dopaminergic neuronal activity. Brain Res. 506, 133-138.
35. Mayeux R., Denaro J., Hemenegildo N., Marder K., Tang M.-X., Cote L. J., and Stern Y. (1992) A population based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch. Neurol. 49, 492-497.
36. McDermott J. L. (1993) Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats. Brain Res. 606, 118-125.
37. McDermott J. L., Kreutzberg J. D., Liu B., and Dluzen D. E. (1994a) Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Horm. Behav. 28, 16-28.
38. McDermott J. L., Liu B., and Dluzen D. E. (1994b) Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp. Neurol. 125, 306-311.
39. Michel M. C., Roth A., Hiemke C., and Ghraf R. (1987) Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochem. Pharmacol. 36, 3175-3180.
40. Morissette M. and Di Paolo T. (1993) Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60, 1876-1883.
41. Morissette M., Biron D., and Di Paolo T. (1990) Effect of estradiol and progesterone on rat striatal dopamine uptake sites. Brain Res. Bull. 25, 419-422.
42. Morissette M., Garcia-Segura L.-M., Belanger A., and Di Paolo T. (1992) Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 49, 893-902.
43. Papavasiliou P. S., Miller S. T., Thai L. J., Nerder L. J., Houlihan G., Rao S. N., and Stevens J M. (1981) Age-related motor and catecholamine alterations in mice on levodopa supplemented diet. Life Sci. 28, 2945-2952.
44. Pifl C., Giros B., and Caron M. G. (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methy 1-4-phenylpyridinium. J. Neurosci. 13, 4246-4253.
45. Ramirez V. D. (1983) Hormones and striatal dopaminergic activity: a novel neuroendocrine model, in The Anterior Pituitary Gland (Bhatnagar A. S., ed), pp. 97-105. Raven Press, New York.
46. Ramirez V. D., Kim K., and Dluzen D. (1985) Progesterone action on the LHRH and nigrostriatal dopamine neuronal systems: in vitro and in vivo studies. Recent Prog. Horm. Res. 41, 421-472.
47. Robinson T. E., Camp D. M., Jacknow D. S., and Becker J. B. (1982) Sex differences and estrous cycle dependent variation in rotational behavior elicited by electrical stimulation of the mesostriatal dopamine system. Behav. Brain Res. 6, 273-287.
48. Roy E. J., Buyer D. R., and Licari V. A. (1990) Estradiol in the striatum: effects on behavior and dopamine receptors but no evidence for membrane steroid receptors. Brain Res. Bull. 25, 221-227.
49. Singer T. P., Salach J. I., Castagnoli N. Jr., and Trevor A. (1986) Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Biochem. J. 235, 785-789.
50. Singer T. P., Castagnoli N. Jr., Ramsay R. R., and Trevor A. J. (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 49, 1-8.
51. Smith R. L. and van Hartesveldt C. (1985) Effects of ovariectomy and estrogen replacement on intrastriatal dopamine-elicited postural deviation. Pharmacol. Biochem. Behav. 22, 689-693.
52. Snyder G. L., Keller R. W. Jr., and Zigmond M. J. (1990) Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J. Pharmacol. Exp. Ther. 253, 867-876.
53. Sziraki J., Kardos V., Patthy M., Patfalusi M., and Budai G. (1994) Methamphetamine protects against MPTP neurotoxicity in C57B1 mice. Eur. J. Pharmacol. 251, 311-314.
54. Unzeta M., Baron S., Perez V., Ambrosto S., and Mahy N. (1994) Sex related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment may be related to differences in monoamine oxidase B. Neurosci. Lett. 176, 235-238.
55. van Hartesveldt C. and Joyce J. N. (1986) Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10, 1-14.